Picture of CVS Health logo

CVS — CVS Health News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareBalancedLarge CapSuper Stock

Brief: CVS Expects FY Adj EPS $7.90 To $8.10 VS IBES Estimate $7.45

BRIEF-CVS Expects FY Adj EPS $7.90 To $8.10 VS IBES Estimate $7.45

- CVS Health Corporation CVS.N:

  • CVS Q2 ADJUSTED EPS $2.58 VERSUS. IBES ESTIMATE $1.85

  • CVS OUTLOOK FY ADJUSTED EPS $7.90 TO $8.10 VERSUS. IBES ESTIMATE $7.45

  • CVS Q2 REVENUE $106.10 BILLION VERSUS. IBES ESTIMATE $100.11 BILLION

  • CVS: MAINTAINING CAUTIOUS VIEW FOR REMAINDER OF YEAR IN LIGHT OF CONTINUED ELEVATED COST TRENDS, POTENTIAL FOR MACRO HEADWINDS

  • CVS: BY EARLY Q4, ZEPBOUND & FOUNDAYO PATIENTS TO BE ABLE TO VIEW TRANSPARENT PRICING, INCLUDING CASH-PAY OPTIONS

  • CVS OUTLOOK FY CASH FLOW FROM OPERATIONS TO AT LEAST $11.5 BILLION

  • CVS: TO OFFER $29 MINUTECLINIC VIRTUAL VISITS FOR PATIENTS SEEKING GLP-1 MEDICATIONS

  • CVS Q2 MEDICAL BENEFIT RATIO AT 87.4% VERSUS IBES ESTIMATE 90.03%


((Reuters.Briefs@thomsonreuters.com;))

Recent news on CVS Health

See all news